REVERPLEG 40 IU/2 ml, concentrate for solution for infusion 10 ampoules of 2 ml
Active ingredients: Argipressin monoacetate, ARGIPRESSINE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion10 ampoules of 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REVERPLEG 40 U.I./2 mL, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 2 ml
- Marketing authorisation holder
- ORPHA DEVEL HANDELS & VERTRIEBS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Jan 2019
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66677526CIP75505564CIP133400955055648Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ARGIPRESSINEsolution | 40 UI · une ampoule de 2 mL de solution à diluer pour perfusion | FT |
| ACÉTATE D'ARGIPRESSINEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.